Evidence map›Paper›PMID 26671012›Full record

ArticleMalaria journal2015

Burden of malaria among adult patients attending general medical outpatient department and HIV care and treatment clinics in Oromia, Ethiopia: a comparative cross-sectional study.

Guda Alemayehu, Zenebe Melaku, Tesfay Abreha, Bereket Alemayehu, Samuel Girma, Yehualashet Tadesse, Tsigereda Gadisa, Sileshi Lulseged, Taye Tolera Balcha, David Hoos and 2 more

Open access · goldAbstract readComparative Study
In one paragraph

Article in Malaria journal, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 4 pooled it
1.0field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 4 syntheses or guidelines pooled it, 21 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 2 countries.

Guda AlemayehuU.S. Agency for International Development (USAID), Addis Ababa, Ethiopia. gudalem@gmail.com.
Zenebe MelakuColumbia University ICAP, Addis Ababa, Ethiopia. zy2115@columbia.edu.
Tesfay AbrehaColumbia University ICAP, Addis Ababa, Ethiopia. ta2265@columbia.edu.
Bereket AlemayehuColumbia University ICAP, New York, USA. bh2267@columbia.edu.
Samuel GirmaColumbia University ICAP, Addis Ababa, Ethiopia. sg2643@columbia.edu.
Yehualashet TadesseColumbia University ICAP, Addis Ababa, Ethiopia. yehualashet2011@yahoo.com.
Tsigereda GadisaColumbia University ICAP, Addis Ababa, Ethiopia. tg2244@columbia.edu.
Sileshi LulsegedColumbia University ICAP, Addis Ababa, Ethiopia. sl2883@columbia.edu.
Taye Tolera BalchaOromia Regional Health Bureau and Federal Ministry of Health Addis Ababa, Addis Ababa, Ethiopia. tayetolera@yahoo.com.
David HoosColumbia University ICAP, New York, USA. davidhoos310@gmail.com.
Hiwot TekaU.S. Agency for International Development (USAID), Addis Ababa, Ethiopia. hiwtek@yahoo.com.
Richard ReithingerRTI International, Washington D.C., USA. rreithinger@yahoo.co.uk.
Addis Ababa University · ETColumbia University · USUnited States Agency for International Development · USFederal Ministry of Health · ETRTI International · US

Funding

PEPFAR
6 · The paper itself

Abstract

backgroundMalaria and HIV/AIDS constitute major public health problems in Ethiopia, but the burden associated with malaria-HIV co-infection has not been well documented. In this study, the burden of malaria among HIV positive and HIV negative adult outpatients attending health facilities in Oromia National Regional State, Ethiopia was investigated.

methodsA comparative cross-sectional study among HIV-positive patients having routine follow-up visits at HIV care and treatment clinics and HIV-seronegative patients attending the general medical outpatient departments in 12 health facilities during the peak malaria transmission season was conducted from September to November, 2011. A total of 3638 patients (1819 from each group) were enrolled in the study. Provider initiated testing and counseling of HIV was performed for 1831 medical outpatients out of whom 1819 were negative and enrolled into the study. Malaria blood microscopy and hemoglobin testing were performed for all 3638 patients. Data was analyzed using descriptive statistics, Chi square test and multivariate logistic regression.

resultsOf the 3638 patients enrolled in the study, malaria parasitaemia was detected in 156 (4.3%); malaria parasitaemia prevalence was 0.7% (13/1819) among HIV-seropositive patients and 7.9% (143/1819) among HIV-seronegative patients. Among HIV-seropositive individuals 65.4% slept under a mosquito bed net the night before data collection, compared to 59.4% of HIV-seronegative individuals. A significantly higher proportion of HIV-seropositive malaria-negative patients were on co-trimoxazole (CTX) prophylaxis as compared to HIV-malaria co-infected patients: 82% (1481/1806) versus 46% (6/13) (P = 0.001). HIV and malaria co-infected patients were less likely to have the classical symptoms of malaria (fever, chills and headache) compared to the HIV-seronegative and malaria positive counterparts. Multivariate logistic regression showed that HIV-seropositive patients who come for routine follow up were less likely to be infected by malaria (OR = 0.23, 95% CI = 0.09-0.74).

conclusionThe study documented lower malaria prevalence among the HIV-seropositive attendants who come for routine follow up. Clinical symptoms of malaria were more pronounced among HIV-seronegative than HIV-seropositive patients. This study also re-affirmed the importance of co-trimoxazole in preventing malaria symptoms and parasitaemia among HIV-positive patients.

Indexed as

OutpatientsAdolescentAdultAgedAged, 80 and overAnti-Infective AgentsChemopreventionCoinfectionCross-Sectional StudiesEthiopiaFemaleHIV InfectionsHumansMalariaMaleMiddle AgedAnti-Infective AgentsTrimethoprim, Sulfamethoxazole Drug Combination

Identifiers

PMID26671012
PMCPMC4681039
OpenAlexW2220333712

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.